Clinical Trial Update: Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use [Phase 2]

View source ↗

Summary

This page reports a Phase 2 clinical trial evaluating cannabidiol as treatment for non-affective psychosis within the schizophrenia spectrum and for cannabis us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder
• Schizophrenia Spectrum and Other Psychotic Disorders

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Lone Baandrup | Conditions: Dual Diagnosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING